Verve has hired Barrett Bischoff as a Talent Agent who will be based in New York, promoting the L.A.-based Lacey Hunsucker to ...

Ben Leonberg, the director of 'Good Boy,' has signed with Verve, which will handle sales for his SXSW-bound horror-thriller ...

Verve Therapeutics remains a high-reward investment despite setbacks. Click here to find out why VERV stock is a Buy.

Initial data from the Heart-2 Phase 1b clinical trial of VERVE-102 targeting PCSK9 expected in the second quarter of 2025, ...

H.C. Wainwright analyst Mitchell Kapoor raised the firm’s price target on Verve Therapeutics (VERV) to $15 from $14 and keeps a Buy rating on ...

Verve offered few details on the early end of a collaboration the companies inked in 2022, saying only that Vertex cited ...

Vertex has backed out of its in vivo gene editing collaboration with Verve Therapeuti | Vertex has backed out of its in vivo ...

AI, human and cultural understanding business Verve has named Peter Latham as director as part of 11 promotions at the ...

In one of the most exciting and dramatic awards seasons ever, the field is wide open in several fields. Here are the BBC film ...

The companies were two years into a four-year, $400 million agreement aimed at developing and marketing gene therapies ...

Verve Therapeutics Inc. (VERV) on Thursday reported a loss of $50 million in its fourth quarter. The Boston-based company said it had a loss of 58 cents per share. The results beat Wall Street ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Verve Therapeutics (VERV – Research Report), ...